A Novel Isaindigotone Derivative Displays Better Anti-Proliferation Activities and Induces Apoptosis in Gastric Cancer Cells

被引:7
作者
Du, Kangjia [1 ]
Yang, Chengjie [1 ]
Zhou, Zhongkun [1 ]
Ma, Yunhao [1 ]
Tian, Yanan [1 ]
Zhang, Rentao [1 ]
Zhang, Hao [1 ]
Jiang, Xinrong [1 ]
Zhu, Hongmei [1 ]
Liu, Huanxiang [1 ]
Chen, Peng [1 ]
Liu, Yingqian [1 ]
机构
[1] Lanzhou Univ, Sch Pharm, 199 Donggang West Rd, Lanzhou 730020, Peoples R China
关键词
gastric cancer; isaindigotone; anti-proliferation; mitochondrial potential; C-MYC TRANSCRIPTION; DESIGN; INHIBITORS; ACETYLCHOLINESTERASE; INFLAMMATION; MECHANISMS; NM23-H2;
D O I
10.3390/ijms23148028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Isaindigotone is an alkaloid containing a pyrrolo-[2,1-b]quinazoline moiety conjugated with a benzylidene group and isolated from the root of Isatis indigotca Fort. However, further anticancer activities of this alkaloid and its derivatives have not been fully explored. In this work, a novel isaindigotone derivative was synthesized and three different gastric cell lines and one human epithelial gastric cell line were used to study the anti-proliferation effects of the novel isaindigotone derivative BLG26. HGC27 cells and AGS cells were used to further explore the potential mechanisms. BLG26 exhibited better anti-proliferation activities in AGS cells with a half-maximal inhibitory concentration (IC50) of 1.45 mu M. BLG26 caused mitochondrial membrane potential loss and induced apoptosis in both HGC27 cells and AGS cells by suppressing mitochondrial apoptotic pathway and PI3K/AKT/mTOR axis. Acute toxicity experiment showed that LD50 (median lethal dose) of BLG26 was above 1000.0 mg/kg. This research suggested that BLG26 can be a potential candidate for the treatment of gastric cancer.
引用
收藏
页数:17
相关论文
共 45 条
[1]   Tunicamycin enhances the suppressive effects of cisplatin on lung cancer growth through PTX3 glycosylation via AKT/NF-B signaling pathway [J].
Ahmmed, Bulbul ;
Khan, Muhammad Noman ;
Nisar, Muhammad Azhar ;
Kampo, Sylvanus ;
Zheng, Qin ;
Li, Yulin ;
Yan, Qiu .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2019, 54 (02) :431-442
[2]   Pharmacoinformatic Approaches to Design Novel Inhibitors of Protein Kinase B Pathways in Cancer [J].
Akhtar, Noreen ;
Jabeen, Ishrat .
CURRENT CANCER DRUG TARGETS, 2018, 18 (09) :830-846
[3]   Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next? [J].
Ala, Moein ;
Ala, Mahan .
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2021, 4 (06) :1747-1770
[4]   Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria [J].
Antonsson, B ;
Montessuit, S ;
Lauper, S ;
Eskes, R ;
Martinou, JC .
BIOCHEMICAL JOURNAL, 2000, 345 :271-278
[5]   Mechanisms of development of multimorbidity in the elderly [J].
Barnes, Peter J. .
EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (03) :790-806
[6]   Mitochondria as multifaceted regulators of cell death [J].
Bock, Florian J. ;
Tait, Stephen W. G. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2020, 21 (02) :85-100
[7]   Role of a Novel PH-Kinase Domain Interface in PKB/Akt Regulation: Structural Mechanism for Allosteric Inhibition [J].
Calleja, Veronique ;
Laguerre, Michel ;
Parker, Peter J. ;
Larijani, Banafshe .
PLOS BIOLOGY, 2009, 7 (01) :189-200
[8]   Cancer Statistics in China, 2015 [J].
Chen, Wanqing ;
Zheng, Rongshou ;
Baade, Peter D. ;
Zhang, Siwei ;
Zeng, Hongmei ;
Bray, Freddie ;
Jemal, Ahmedin ;
Yu, Xue Qin ;
He, Jie .
CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) :115-132
[9]   Natural Products as a Vital Source for the Discovery of Cancer Chemotherapeutic and Chemopreventive Agents [J].
Cragg, Gordon M. ;
Pezzuto, John M. .
MEDICAL PRINCIPLES AND PRACTICE, 2016, 25 :41-59
[10]   A Network Pharmacology-Based Investigation to the Pharmacodynamic Material Basis and Mechanisms of the Anti-Inflammatory and Anti-Viral Effect of Isatis indigotica [J].
Deng, Jiuling ;
Ma, Ying ;
He, Yuqiong ;
Yang, Hong ;
Chen, Yanhong ;
Wang, Liang ;
Huang, Doudou ;
Qiu, Shi ;
Tao, Xia ;
Chen, Wansheng .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 :3193-3206